BHCM
RXST icon

Brevan Howard Capital Management’s RxSight RXST Stock Holding History

Brevan Howard Capital Management’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87.7K Buy
18,202
+6,828
+60% +$41.2K ﹤0.01% 1995
2026
Q1 		$70.1K Sell
11,374
-18,119
-61% -$150K ﹤0.01% 2062
2025
Q4 		$307K Buy
29,493
+7,877
+36% +$79K ﹤0.01% 1363
2025
Q3 		$194K Buy
21,616
+8,459
+64% +$74.2K ﹤0.01% 1762
2025
Q2 		$171K Buy
+13,157
New +$198K ﹤0.01% 1739

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Brevan Howard Capital Management's RXST Position: Q2 2026 in Review

Brevan Howard Capital Management increased its RxSight (RXST) stake by 60% in Q2 2026, buying an estimated $41.2K and bringing the position to 18,202 shares worth $87.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1995.

Brevan Howard Capital Management first reported a position in RXST in Q2 2025 and has held it in 5 quarters since. The position peaked at $307K in Q4 2025. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Brevan Howard Capital Management held 18,202 shares of RxSight worth $87.7K as of Q2 2026.
  • Brevan Howard Capital Management bought 6,828 RxSight shares in Q2 2026, an estimated $41.2K.
  • RxSight made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1995 holding.
  • Brevan Howard Capital Management first reported a position in RxSight in Q2 2025 and has held it in 5 quarters since.
  • Brevan Howard Capital Management's RxSight position peaked at $307K in Q4 2025.
  • 152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.